Influence of sequence variation on the RNA cleavage activity of Zn2+-dimethyl-dppz-PNA-based artificial enzymesShow others and affiliations
2022 (English)In: RSC Advances, E-ISSN 2046-2069, Vol. 12, no 9, p. 5398-5406Article in journal (Refereed) Published
Abstract [en]
The development of Zn2+-dependent dimethyl-dppz-PNA conjugates (PNAzymes) as efficient site-specific artificial ribonucleases enables rapid sequence-specific degradation of clinically relevant RNA target sequences, but the significance of the RNA/PNAzyme sequence and structural demands for the identification of novel RNA targets are not fully understood. In the present study, we investigated the influence of sequence variation in the recognition arms of the RNA/PNAzyme complex on the RNA cleavage activity of the artificial enzymes. The base pairs closing the 3-nucleotide bulge region on both sides of the bulge as well as the neighbouring nucleobases were shown to significantly influence the RNA cleavage activity. Elongation of the RNA/PNAzyme complex was shown to be tolerated, although potentially prohibitive for catalytic turnover. The specificity of PNAzyme action was clearly demonstrated by the significantly reduced or absent cleavage activity in complexes containing mismatches. Further investigation into 2- and 4-nucleotide RNA bulges indicated that formation of 3-nucleotide bulges in the target RNA gives the optimal cleavage rates, while some potential off-target cleavage of formed 4-nucleotide bulges of select sequences should be considered.
Place, publisher, year, edition, pages
Royal Society of Chemistry , 2022. Vol. 12, no 9, p. 5398-5406
Keywords [en]
Enzymes, Artificial enzymes, Base pairs, Catalytic turnover, Cleavage activities, Nucleobases, RNA cleavage, Sequence variations, Site-specific, Target sequences, Zn 2+, RNA
National Category
Biochemistry and Molecular Biology
Identifiers
URN: urn:nbn:se:ri:diva-58779DOI: 10.1039/d1ra08319hScopus ID: 2-s2.0-85125076771OAI: oai:DiVA.org:ri-58779DiVA, id: diva2:1642213
Note
Funding details: 721613; Funding details: Horizon 2020; Funding text 1: The authors would like to extend their gratitude to Rouven Stulz and the Separation Science Laboratory at AstraZeneca Gothenburg for their help with RNA synthesis and purication. This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 721613. This material reects only the authors' views and the Union is not liable for any use that may be made of the information contained therein.
2022-03-042022-03-042024-06-26Bibliographically approved